{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:16:40Z","timestamp":1793301400677,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13346-025-01852-6","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T10:33:43Z","timestamp":1745490823000},"page":"2115-2129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oral peptide drug delivery: design of SEDDS providing a protective effect against intestinal membrane-bound enzymes"],"prefix":"10.1007","volume":"16","author":[{"given":"Annika","family":"Postina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Z\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-8277","authenticated-orcid":false,"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"1852_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20:309\u201325. https:\/\/doi.org\/10.1038\/s41573-020-00135-8.","journal-title":"Nat Rev Drug Discov"},{"key":"1852_CR2","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","volume":"25","author":"J Reinholz","year":"2018","unstructured":"Reinholz J, Landfester K, Mail\u00e4nder V. The challenges of oral drug delivery via nanocarriers. Drug Deliv. 2018;25:1694\u2013705. https:\/\/doi.org\/10.1080\/10717544.2018.1501119.","journal-title":"Drug Deliv"},{"key":"1852_CR3","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0142-9612(00)00039-9","volume":"21","author":"MK Marsch\u00fctz","year":"2000","unstructured":"Marsch\u00fctz MK, Bernkop-Schn\u00fcrch A. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro. Biomaterials. 2000;21:1499\u2013507.","journal-title":"Biomaterials"},{"key":"1852_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","volume":"52","author":"A Bernkop-Schn\u00fcrch","year":"1998","unstructured":"Bernkop-Schn\u00fcrch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release. 1998;52:1\u201316.","journal-title":"J Control Release"},{"key":"1852_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","volume":"19","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020;19:277\u201389. https:\/\/doi.org\/10.1038\/s41573-019-0053-0.","journal-title":"Nat Rev Drug Discov"},{"key":"1852_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2018.183","volume":"18","author":"AC Anselmo","year":"2019","unstructured":"Anselmo AC, Gokarn Y, Mitragotri S. Non-invasive delivery strategies for biologics. Nat Rev Drug Discov. 2019;18:19\u201340. https:\/\/doi.org\/10.1038\/nrd.2018.183.","journal-title":"Nat Rev Drug Discov"},{"key":"1852_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/J.EJPS.2015.10.005","volume":"81","author":"O Zupan\u010di\u010d","year":"2016","unstructured":"Zupan\u010di\u010d O, Partenhauser A, Lam HT, Rohrer J, Bernkop-Schn\u00fcrch A. Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin. Eur J Pharm Sci. 2016;81:129\u201336. https:\/\/doi.org\/10.1016\/J.EJPS.2015.10.005.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"1852_CR8","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.3109\/10717544.2016.1143056","volume":"23","author":"O Zupan\u010di\u010d","year":"2016","unstructured":"Zupan\u010di\u010d O, Leonaviciute G, Lam HT, Partenhauser A, Podri\u010dnik S, Bernkop-Schn\u00fcrch A. Development and in vitro evaluation of an oral SEDDS for desmopressin. Drug Deliv. 2016;23(6):2074\u201383. https:\/\/doi.org\/10.3109\/10717544.2016.1143056.","journal-title":"Drug Deliv"},{"key":"1852_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/J.IJPHARM.2017.03.027","volume":"523","author":"G Het\u00e9nyi","year":"2017","unstructured":"Het\u00e9nyi G, Griesser J, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm. 2017;523:357\u201365. https:\/\/doi.org\/10.1016\/J.IJPHARM.2017.03.027.","journal-title":"Int J Pharm"},{"key":"1852_CR10","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1016\/J.XPHS.2020.05.005","volume":"109","author":"P Jirwankar","year":"2020","unstructured":"Jirwankar P, Shah D, Shao J. Protection of protein drugs by self-emulsified nanoemulsion against proteolysis. J Pharm Sci. 2020;109:2615\u201321. https:\/\/doi.org\/10.1016\/J.XPHS.2020.05.005.","journal-title":"J Pharm Sci"},{"key":"1852_CR11","doi-asserted-by":"publisher","first-page":"114097","DOI":"10.1016\/J.ADDR.2021.114097","volume":"182","author":"S Haddadzadegan","year":"2022","unstructured":"Haddadzadegan S, Dorkoosh F, Bernkop-Schn\u00fcrch A. Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev. 2022;182:114097. https:\/\/doi.org\/10.1016\/J.ADDR.2021.114097.","journal-title":"Adv Drug Deliv Rev"},{"key":"1852_CR12","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41598-017-01542-5","volume":"7","author":"S Joshi","year":"2017","unstructured":"Joshi S, Chen L, Winter MB, Lin Y-L, Yang Y, Shapovalova M, Smith PM, Liu C, Li F, LeBeau AM. The rational design of therapeutic peptides for aminopeptidase N using a substrate-based approach. Sci Rep. 2017;7:1424. https:\/\/doi.org\/10.1038\/s41598-017-01542-5.","journal-title":"Sci Rep"},{"key":"1852_CR13","doi-asserted-by":"publisher","unstructured":"Siebert A, Gensicka-Kowalewska M, Cholewinski G, Dzierzbicka K. Tuftsin \u2013 properties and analogs. Curr Med Chem. 2017;24. https:\/\/doi.org\/10.2174\/0929867324666170725140826.","DOI":"10.2174\/0929867324666170725140826"},{"key":"1852_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","volume":"14","author":"P Mina-Osorio","year":"2008","unstructured":"Mina-Osorio P. The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med. 2008;14:361\u201371.","journal-title":"Trends Mol Med"},{"key":"1852_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/J.EJPB.2022.05.003","volume":"176","author":"K Z\u00f6ller","year":"2022","unstructured":"Z\u00f6ller K, To D, Knoll P, Bernkop-Schn\u00fcrch A. Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin. Eur J Pharm Biopharm. 2022;176:32\u201342. https:\/\/doi.org\/10.1016\/J.EJPB.2022.05.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"1852_CR16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1021\/bm2017993","volume":"13","author":"S Jain","year":"2012","unstructured":"Jain S, Amiji M. Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system. Biomacromol. 2012;13:1074\u201385. https:\/\/doi.org\/10.1021\/bm2017993.","journal-title":"Biomacromol"},{"key":"1852_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jcis.2022.07.160","volume":"628","author":"P Knoll","year":"2022","unstructured":"Knoll P, H\u00f6rmann N, Le Nguyen N-M, Wibel R, Gust R, Bernkop-Schn\u00fcrch A. Charge converting nanostructured lipid carriers containing a cell-penetrating peptide for enhanced cellular uptake. J Colloid Interface Sci. 2022;628:463\u201375. https:\/\/doi.org\/10.1016\/j.jcis.2022.07.160.","journal-title":"J Colloid Interface Sci"},{"key":"1852_CR18","doi-asserted-by":"publisher","first-page":"122476","DOI":"10.1016\/j.ijpharm.2022.122476","volume":"631","author":"R Wibel","year":"2023","unstructured":"Wibel R, J\u00f6rgensen AM, Laffleur F, Spleis H, Claus V, Bernkop-Schn\u00fcrch A. Oral delivery of calcitonin-ion pairs: In vivo proof of concept for a highly lipophilic counterion. Int J Pharm. 2023;631:122476. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122476.","journal-title":"Int J Pharm"},{"key":"1852_CR19","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1021\/acsbiomaterials.0c00637","volume":"6","author":"TNQ Phan","year":"2020","unstructured":"Phan TNQ, Ismail R, Le-Vinh B, Zaichik S, Laffleur F, Bernkop-Schn\u00fcrch A. The effect of counterions in hydrophobic ion pairs on oral bioavailability of exenatide. ACS Biomater Sci Eng. 2020;6:5032\u20139. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c00637.","journal-title":"ACS Biomater Sci Eng"},{"key":"1852_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejpb.2019.09.022","volume":"144","author":"J Liu","year":"2019","unstructured":"Liu J, Xu Y, Liu Z, Ren H, Meng Z, Liu K, Liu Z, Yong J, Wang Y, Li X. A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres. Eur J Pharm Biopharm. 2019;144:217\u201329. https:\/\/doi.org\/10.1016\/j.ejpb.2019.09.022.","journal-title":"Eur J Pharm Biopharm"},{"key":"1852_CR21","doi-asserted-by":"publisher","first-page":"2302034","DOI":"10.1002\/adhm.202302034","volume":"12","author":"AM J\u00f6rgensen","year":"2023","unstructured":"J\u00f6rgensen AM, Steinbring C, Stengel D, To D, Schmid P, Bernkop-Schn\u00fcrch A. Self-emulsifying drug delivery systems (SEDDS) containing reverse micelles: advanced oral formulations for therapeutic peptides. Adv Healthc Mater. 2023;12:2302034. https:\/\/doi.org\/10.1002\/adhm.202302034.","journal-title":"Adv Healthc Mater"},{"key":"1852_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijpharm.2017.02.019","volume":"520","author":"J Griesser","year":"2017","unstructured":"Griesser J, Het\u00e9nyi G, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm. 2017;520:267\u201374. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.019.","journal-title":"Int J Pharm"},{"key":"1852_CR23","doi-asserted-by":"publisher","first-page":"104686","DOI":"10.1016\/j.jddst.2023.104686","volume":"86","author":"K Z\u00f6ller","year":"2023","unstructured":"Z\u00f6ller K, Laffleur F, Claus V, Knoll P, To D, Bernkop-Schn\u00fcrch A. Development and in vivo evaluation of nanoemulsions for oral delivery of low molecular weight heparin. J Drug Deliv Sci Technol. 2023;86:104686. https:\/\/doi.org\/10.1016\/j.jddst.2023.104686.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1852_CR24","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2217\/nnm-2020-0127","volume":"15","author":"JD Friedl","year":"2020","unstructured":"Friedl JD, Steinbring C, Zaichik S, Le N-MN, Bernkop-Schn\u00fcrch A. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface. Nanomedicine. 2020;15:1829\u201341. https:\/\/doi.org\/10.2217\/nnm-2020-0127.","journal-title":"Nanomedicine"},{"key":"1852_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1023\/A:1012108118670","volume":"14","author":"A Bernkop-Schn\u00fcrch","year":"1997","unstructured":"Bernkop-Schn\u00fcrch A, Paikl C, Valenta C. Novel bioadhesive chitosan-EDTA conjugate protects Leu-Enkephalin from degradation by aminopeptidase n. Pharm Res. 1997;14:917\u201322.","journal-title":"Pharm Res"},{"key":"1852_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/jps.1140","volume":"90","author":"A Bernkop-Schn\u00fcrch","year":"2001","unstructured":"Bernkop-Schn\u00fcrch A, Zarti H, Walker GF. Thiolation of polycarbophil enhances its inhibition of intestinal brush border membrane bound aminopeptidase N. J Pharm Sci. 2001;90:1907\u201314.","journal-title":"J Pharm Sci"},{"key":"1852_CR27","doi-asserted-by":"publisher","first-page":"105544","DOI":"10.1016\/j.pep.2019.105544","volume":"167","author":"X Lin","year":"2020","unstructured":"Lin X, Dong L, Yu D, Wang B, Pan L. High-level expression and characterization of the thermostable leucine aminopeptidase Thelap from the thermophilic fungus Thermomyces lanuginosus in Aspergillus niger and its application in soy protein hydrolysis. Protein Expr Purif. 2020;167:105544. https:\/\/doi.org\/10.1016\/j.pep.2019.105544.","journal-title":"Protein Expr Purif"},{"key":"1852_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpharm.2017.04.058","volume":"526","author":"N Lupo","year":"2017","unstructured":"Lupo N, Fidahic U, Het\u00e9nyi G, Griesser J, Bernkop-Schn\u00fcrch A. Inhibitory effect of emulsifiers in sedds on protease activity: just an illusion? Int J Pharm. 2017;526:23\u201330. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.04.058.","journal-title":"Int J Pharm"},{"key":"1852_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejps.2016.10.006","volume":"96","author":"M Miyake","year":"2017","unstructured":"Miyake M, Koga T, Kondo S, Yoda N, Emoto C, Mukai T, Toguchi H. Prediction of drug intestinal absorption in human using the Ussing chamber system: a comparison of intestinal tissues from animals and humans. Eur J Pharm Sci. 2017;96:373\u201380. https:\/\/doi.org\/10.1016\/j.ejps.2016.10.006.","journal-title":"Eur J Pharm Sci"},{"key":"1852_CR30","doi-asserted-by":"publisher","first-page":"113795","DOI":"10.1016\/j.addr.2021.05.005","volume":"175","author":"Y Xu","year":"2021","unstructured":"Xu Y, Shrestha N, Pr\u00e9at V, Beloqui A. An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers. Adv Drug Deliv Rev. 2021;175:113795. https:\/\/doi.org\/10.1016\/j.addr.2021.05.005.","journal-title":"Adv Drug Deliv Rev"},{"key":"1852_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57. https:\/\/doi.org\/10.3390\/pharmaceutics10020057.","journal-title":"Pharmaceutics"},{"issue":"11","key":"1852_CR32","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1039\/C9NA00308H","volume":"1","author":"KD Ristroph","year":"2019","unstructured":"Ristroph KD, Prud\u2019homme RK. Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1(11):4207\u201337. https:\/\/doi.org\/10.1039\/C9NA00308H.","journal-title":"Nanoscale Adv"},{"key":"1852_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0378-5173(00)00457-9","volume":"203","author":"SH Choi","year":"2000","unstructured":"Choi SH, Park TG. Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres. Int J Pharm. 2000;203:193\u2013202. https:\/\/doi.org\/10.1016\/S0378-5173(00)00457-9.","journal-title":"Int J Pharm"},{"key":"1852_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejpb.2020.04.004","volume":"151","author":"R Wibel","year":"2020","unstructured":"Wibel R, Friedl JD, Zaichik S, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing (HIP) of (poly)peptide drugs: benefits and drawbacks of different preparation methods. Eur J Pharm Biopharm. 2020;151:73\u201380. https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"1852_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejpb.2020.04.025","volume":"152","author":"R Ismail","year":"2020","unstructured":"Ismail R, Phan TNQ, Laffleur F, Cs\u00f3ka I, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. Eur J Pharm Biopharm. 2020;152:10\u20137. https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.025.","journal-title":"Eur J Pharm Biopharm"},{"key":"1852_CR36","doi-asserted-by":"publisher","first-page":"123507","DOI":"10.1016\/j.ijpharm.2023.123507","volume":"647","author":"V Claus","year":"2023","unstructured":"Claus V, Sandmeier M, Hock N, Spleis H, Lindner S, Kalb M, Bernkop-Schn\u00fcrch A. Counterion optimization for hydrophobic ion pairing (HIP): unraveling the key factors. Int J Pharm. 2023;647:123507. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123507.","journal-title":"Int J Pharm"},{"key":"1852_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2017.12.027","volume":"271","author":"A Bernkop-Schn\u00fcrch","year":"2018","unstructured":"Bernkop-Schn\u00fcrch A, Jalil A. Do drug release studies from SEDDS make any sense? J Control Release. 2018;271:55\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.027.","journal-title":"J Control Release"},{"key":"1852_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-3659(96)01586-6","volume":"46","author":"P Langguth","year":"1997","unstructured":"Langguth P, Bohner V, Heizmann J, Merkle HP, Wolffram S, Amidon GL, Yamashita S. The challenge of proteolytic enzymes in intestinal peptide delivery. J Control Release. 1997;46:39\u201357. https:\/\/doi.org\/10.1016\/S0168-3659(96)01586-6.","journal-title":"J Control Release"},{"key":"1852_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.colsurfb.2018.03.034","volume":"167","author":"K AboulFotouh","year":"2018","unstructured":"AboulFotouh K, Allam AA, El-Badry M, El-Sayed AM. Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability. Colloids Surf B Biointerfaces. 2018;167:82\u201392. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.03.034.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1852_CR40","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1021\/acsbiomaterials.2c01504","volume":"9","author":"H Spleis","year":"2023","unstructured":"Spleis H, Federer C, Claus V, Sandmeier M, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing of small molecules: how to minimize premature drug release from SEDDS and reach the absorption membrane in intact form. ACS Biomater Sci Eng. 2023;9:1450\u20139. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c01504.","journal-title":"ACS Biomater Sci Eng"},{"key":"1852_CR41","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3390\/pharmaceutics15071973","volume":"15","author":"J Mudassir","year":"2023","unstructured":"Mudassir J, Raza A, Khan MA, Hameed H, Shazly GA, Irfan A, Rana SJ, Abbas K, Arshad MS, Muhammad S, Bin Jardan YA. Design and evaluation of hydrophobic ion paired insulin loaded self micro-emulsifying drug delivery system for oral delivery. Pharmaceutics. 2023;15:1973. https:\/\/doi.org\/10.3390\/pharmaceutics15071973.","journal-title":"Pharmaceutics"},{"key":"1852_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/pharmaceutics12010017","volume":"12","author":"E Tay","year":"2019","unstructured":"Tay E, Nguyen T-H, Ford L, Williams HD, Benameur H, Scammells PJ, Porter CJH. Ionic Liquid forms of the antimalarial lumefantrine in combination with LFCS type IIIB lipid-based formulations preferentially increase lipid solubility, in vitro solubilization behavior and in vivo exposure. Pharmaceutics. 2019;12:17. https:\/\/doi.org\/10.3390\/pharmaceutics12010017.","journal-title":"Pharmaceutics"},{"key":"1852_CR43","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1080\/10717544.2022.2118399","volume":"29","author":"YT Goo","year":"2022","unstructured":"Goo YT, Lee S, Choi JY, Kim MS, Sin GH, Hong SH, Kim CH, Song SH, Choi YW. Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design. Drug Deliv. 2022;29:2831\u201345. https:\/\/doi.org\/10.1080\/10717544.2022.2118399.","journal-title":"Drug Deliv"},{"key":"1852_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","volume":"142","author":"A Mahmood","year":"2019","unstructured":"Mahmood A, Bernkop-Schn\u00fcrch A. SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2019;142:91\u2013101. https:\/\/doi.org\/10.1016\/j.addr.2018.07.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"1852_CR45","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ejpb.2013.10.015","volume":"86","author":"A Amri","year":"2014","unstructured":"Amri A, Le Clanche S, Th\u00e9rond P, Bonnefont-Rousselot D, Borderie D, Lai-Kuen R, Chaumeil J-C, Sfar S, Charrueau C. Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death. Eur J Pharm Biopharm. 2014;86:418\u201326. https:\/\/doi.org\/10.1016\/j.ejpb.2013.10.015.","journal-title":"Eur J Pharm Biopharm"},{"key":"1852_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0304-4165(83)90363-X","volume":"761","author":"S Miura","year":"1983","unstructured":"Miura S, Song I-S, Morita A, Erickson RH, Kim YS. Distribution and biosynthesis of aminopeptidase n and dipeptidyl aminopeptidase IV in rat small intestine. Biochimica et Biophysica Acta (BBA) - General Subj. 1983;761:66\u201375. https:\/\/doi.org\/10.1016\/0304-4165(83)90363-X.","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subj"},{"key":"1852_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ejps.2010.07.005","volume":"41","author":"A Christiansen","year":"2010","unstructured":"Christiansen A, Backensfeld T, Weitschies W. Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes. Eur J Pharm Sci. 2010;41:376\u201382. https:\/\/doi.org\/10.1016\/j.ejps.2010.07.005.","journal-title":"Eur J Pharm Sci"},{"key":"1852_CR48","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/0006-291X(89)92260-2","volume":"159","author":"F-K Zhao","year":"1989","unstructured":"Zhao F-K, Chuang LF, Israel M, Chuang RY. Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:1359\u201367. https:\/\/doi.org\/10.1016\/0006-291X(89)92260-2.","journal-title":"Biochem Biophys Res Commun"},{"key":"1852_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2021.05.028","volume":"335","author":"A Fedi","year":"2021","unstructured":"Fedi A, Vitale C, Ponschin G, Ayehunie S, Fato M, Scaglione S. In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: a systematic review. J Control Release. 2021;335:247\u201368. https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.028.","journal-title":"J Control Release"},{"key":"1852_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/fft2.44","volume":"1","author":"S Kamiloglu","year":"2020","unstructured":"Kamiloglu S, Sari G, Ozdal T, Capanoglu E. Guidelines for cell viability assays. Food Front. 2020;1:332\u201349. https:\/\/doi.org\/10.1002\/fft2.44.","journal-title":"Food Front"},{"key":"1852_CR51","doi-asserted-by":"publisher","first-page":"121633","DOI":"10.1016\/j.ijpharm.2022.121633","volume":"618","author":"JD Friedl","year":"2022","unstructured":"Friedl JD, J\u00f6rgensen AM, Le Nguyen N-M, Steinbring C, Bernkop-Schn\u00fcrch A. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery. Int J Pharm. 2022;618:121633. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121633.","journal-title":"Int J Pharm"},{"key":"1852_CR52","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.jddst.2020.101772","volume":"58","author":"L Pavoni","year":"2020","unstructured":"Pavoni L, Perinelli DR, Ciacciarelli A, Quassinti L, Bramucci M, Miano A, Casettari L, Cespi M, Bonacucina G, Palmieri GF. Properties and stability of nanoemulsions: how relevant is the type of surfactant? J Drug Deliv Sci Technol. 2020;58:101772. https:\/\/doi.org\/10.1016\/j.jddst.2020.101772.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1852_CR53","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/10837450.2018.1547748","volume":"24","author":"MM Mahboobian","year":"2019","unstructured":"Mahboobian MM, Seyfoddin A, Aboofazeli R, Foroutan SM, Rupenthal ID. Brinzolamide\u2013loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests. Pharm Dev Technol. 2019;24:600\u20136. https:\/\/doi.org\/10.1080\/10837450.2018.1547748.","journal-title":"Pharm Dev Technol"},{"key":"1852_CR54","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/pharmaceutics13081312","volume":"13","author":"I Shahzadi","year":"2021","unstructured":"Shahzadi I, F\u00fcrst A, Knoll P, Bernkop-Schn\u00fcrch A. Nanostructured lipid carriers (NLCs) for oral peptide drug delivery: about the impact of surface decoration. Pharmaceutics. 2021;13:1312. https:\/\/doi.org\/10.3390\/pharmaceutics13081312.","journal-title":"Pharmaceutics"},{"key":"1852_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejps.2018.10.024","volume":"127","author":"GC Meirelles","year":"2019","unstructured":"Meirelles GC, Mendes C, Caon T, Teixeira HF, von Poser G, Ponchel G. Intestinal permeability enhancement of benzopyran HP1-loaded nanoemulsions. Eur J Pharm Sci. 2019;127:115\u201320. https:\/\/doi.org\/10.1016\/j.ejps.2018.10.024.","journal-title":"Eur J Pharm Sci"},{"key":"1852_CR56","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3390\/molecules28062827","volume":"28","author":"A Mahmood","year":"2023","unstructured":"Mahmood A, Khan L, Ijaz M, Nazir I, Naseem M, Tahir MA, Aamir MN, Rehman MU, Asim MH. Enhanced intestinal permeability of cefixime by self-emulsifying drug delivery system: in-vitro and ex-vivo characterization. Molecules. 2023;28:2827. https:\/\/doi.org\/10.3390\/molecules28062827.","journal-title":"Molecules"},{"key":"1852_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/10717540802328599","volume":"15","author":"BS Kim","year":"2008","unstructured":"Kim BS, Won M, Yang LKM, Kim CS. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv. 2008;15:465\u20139. https:\/\/doi.org\/10.1080\/10717540802328599.","journal-title":"Drug Deliv"},{"key":"1852_CR58","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.xphs.2017.03.016","volume":"106","author":"AS Zidan","year":"2017","unstructured":"Zidan AS, Kamal N, Alayoubi A, Seggel M, Ibrahim S, Rahman Z, Cruz CN, Ashraf M. Effect of isopropyl myristate on transdermal permeation of testosterone from carbopol gel. J Pharm Sci. 2017;106:1805\u201313. https:\/\/doi.org\/10.1016\/j.xphs.2017.03.016.","journal-title":"J Pharm Sci"},{"key":"1852_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0378-5173(00)00559-7","volume":"209","author":"E Park","year":"2000","unstructured":"Park E. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm. 2000;209:109\u201319. https:\/\/doi.org\/10.1016\/S0378-5173(00)00559-7.","journal-title":"Int J Pharm"},{"key":"1852_CR60","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/S11095-007-9488-9\/TABLES\/3","volume":"25","author":"K Whitehead","year":"2008","unstructured":"Whitehead K, Karr N, Mitragotri S. Safe and effective permeation enhancers for oral drug delivery. Pharm Res. 2008;25:1782\u20138. https:\/\/doi.org\/10.1007\/S11095-007-9488-9\/TABLES\/3.","journal-title":"Pharm Res"},{"key":"1852_CR61","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.ddtec.2011.11.006","volume":"9","author":"S Maher","year":"2012","unstructured":"Maher S, Brayden DJ. Overcoming poor permeability: translating permeation enhancers for oral peptide delivery. Drug Discov Today Technol. 2012;9:e113\u20139. https:\/\/doi.org\/10.1016\/j.ddtec.2011.11.006.","journal-title":"Drug Discov Today Technol"},{"key":"1852_CR62","doi-asserted-by":"publisher","first-page":"124297","DOI":"10.1016\/j.ijpharm.2024.124297","volume":"660","author":"J Ruan","year":"2024","unstructured":"Ruan J, Liao S, Tang J, Ou Y, Hu X, Li J. The effect of skin diffusion kinetics of isopropyl ester permeation enhancers on drug permeation: role of lateral spread and penetration characteristics. Int J Pharm. 2024;660:124297. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124297.","journal-title":"Int J Pharm"},{"key":"1852_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejpb.2015.04.013","volume":"97","author":"T Karamanidou","year":"2015","unstructured":"Karamanidou T, Karidi K, Bourganis V, Kontonikola K, Kammona O, Kiparissides C. Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur J Pharm Biopharm. 2015;97:223\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2015.04.013.","journal-title":"Eur J Pharm Biopharm"},{"key":"1852_CR64","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/03639045.2017.1338722","volume":"43","author":"O Zupan\u010di\u010d","year":"2017","unstructured":"Zupan\u010di\u010d O, Rohrer J, Thanh Lam H, Grie\u00dfinger JA, Bernkop-Schn\u00fcrch A. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery. Drug Dev Ind Pharm. 2017;43:1694\u2013702. https:\/\/doi.org\/10.1080\/03639045.2017.1338722.","journal-title":"Drug Dev Ind Pharm"},{"key":"1852_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijpharm.2014.05.047","volume":"472","author":"F Hintzen","year":"2014","unstructured":"Hintzen F, Perera G, Hauptstein S, M\u00fcller C, Laffleur F, Bernkop-Schn\u00fcrch A. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm. 2014;472:20\u20136. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.05.047.","journal-title":"Int J Pharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01852-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:50:11Z","timestamp":1782305411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01852-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01852-6","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"30 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}